Evotec SE (EVO) Long-Term Investments (2009 - 2026)
Evotec SE's (EVO) quarterly Long-Term Investments came in at $4.0 million in Q2 2026, down 20.61% year-over-year from $5.1 million in Q2 2025, and down 20.57% quarter-over-quarter from $5.1 million in Q1 2026.
Analysis
Evotec SE (EVO) Long-Term Investments (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Long-Term Investments across 10 years of filings, most recently posting $4.0 million for Q2 2026.
- In Q2 2026, Long-Term Investments fell 20.61% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (down 20.61% YoY), while the FY2025 annual figure was $5.2 million, up 126.01% from the prior year.
- Long-Term Investments came in at $4.0 million for Q2 2026 at Evotec SE, down from $5.1 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $203.7 million in Q2 2022 to a low of $2.3 million in Q4 2024.
- Average Long-Term Investments over 5 years is $20.5 million, with a median of $5.4 million recorded in 2025.
- Year-over-year, Long-Term Investments plunged 94.06% in 2023 and soared 135.85% in 2025.
- Over 5 years, Long-Term Investments stood at $16.4 million in 2022, then plunged by 79.81% to $3.3 million in 2023, then sank by 30.86% to $2.3 million in 2024, then soared by 135.85% to $5.4 million in 2025, then declined by 25.0% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $4.0 million in Q2 2026, $5.1 million in Q1 2026, and $5.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 390.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 107.23 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 206.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 4.04 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 14.78 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 5.09 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 3.30 Mn |
| Jun 30, 2023 | 12.09 Mn |
| Dec 31, 2022 | 16.37 Mn |
| Sep 30, 2022 | 11.61 Mn |
| Jun 30, 2022 | 203.69 Mn |
| Mar 31, 2022 | 18.28 Mn |
| Dec 31, 2021 | 14.95 Mn |
| Sep 30, 2021 | 99.26 Mn |
| Dec 31, 2020 | 47.35 Mn |
| Dec 31, 2019 | 32.95 Mn |
| Sep 30, 2010 | 62.48 Mn |